____________________
Assistive Technologies

U.S. Millipore Execs Visiting Toronto to Formalize Large-scale Stem Cell Cultivation Partnership

Toronto – Millipore executives from Boston, MA, will be in Toronto next week to sign papers and tour the product development facility at the Centre for Commercialization of Regenerative Medicine (CCRM) at the University of Toronto. CCRM, launched in June 2011, has signed its first industry project with EMD Millipore, the Life Sciences division of Merck KGaA, to translate 2D tissue culture vessels into 3D tissue bioreactors .

“We are delighted that Robert Shaw and Knut Niss are coming to Toronto to see where CCRM will be producing stem cells on a scale that is large enough to be cost-effective for clinical use,” says Michael May, CEO of the Centre for Commercialization of Regenerative Medicine. “We anticipate that this project will be the first of many industry collaborations and it’s a pleasure to have our Millipore partners on site to kick this one off.”